|
|
|
|
|
7th Rabi-us-Saani 1436 | Thursday, Jan 29, 2015
Health

Now, cancer-killing cells that can be injected into patients

Saturday, 5 January 2013
Comments(0)
London, January 05:

In a breakthrough, scientists have for the first time created cancer-killing cells which can be directly injected into patients.

Researchers in Japan have created cancer-specific killer T cells, the cells naturally occur in small numbers, but it is hoped injecting huge quantities back into a patient could turbo-charge the immune system, the `Daily Mail` reported.

Researchers at the RIKEN Research Centre for Allergy and Immunology revealed they have succeeded for the first time in creating cancer-specific, immune system cells called killer T lymphocytes, the `Daily Mail` reported.

To create these, the team first had to reprogramme T lymphocytes specialised in killing a certain type of cancer, into another type of cell called induced pluripotent stem cells (iPS cells).

These iPS cells then generated fully active, cancer-specific T lymphocytes. These lymphocytes regenerated from iPS cells could potentially serve as cancer therapy in the future, researchers believe.

Previous research has shown that killer T lymphocytes produced in the lab using conventional methods are inefficient in killing cancer cells mainly because they have a very short life-span, which limits their use as treatment for cancer.

To overcome the problems, Japanese researchers, led by Hiroshi Kawamoto reprogrammed mature human killer T lymphocytes into iPS cells and investigated how these cells differentiate.

The team induced killer T lymphocytes specific for a certain type of skin cancer to reprogramme into iPS cells by exposing the lymphocytes to the `Yamanaka factors` - a group of compounds that induce cells to revert to a non-specialised, stage.

The iPS cells obtained were then grown in the lab and induced to differentiate into killer T lymphocytes again. This new batch of T lymphocytes was shown to be specific for the same type of skin cancer as the original lymphocytes.

They maintained the genetic reorganisation, enabling them to express the cancer-specific receptor on their surface. The new T lymphocytes were also shown to be active and to produce an anti-tumour compound.

"We have succeeded in the expansion of antigen-specific T cells by making iPS cells and differentiating them back into functional T cells," Kawamoto said.

"The next step will be to test whether these T cells can selectively kill tumour cells but not other cells in the body. If they do, these cells might be directly injected into patients for therapy. This could be realised in the not-so-distant future," Kawamoto said.

The findings were published in the journal Cell Stem Cell.

PTI

Latest News

Delhi elections : Modi was wearing Rs 10-lakh suit, Rahul Gandhi says

Congress leader Rahul Gandhi on Thursday hit out at PM Narendra Modi saying that he has 'fooled' the ...

BJP posers: Kejriwal asks why it shying away from debate

AAP chief Arvind Kejriwal today took a jibe at BJP for its plan to pose five questions to him, wonde ...

Three minors injured in Odisha firing

Tension is prevailing at a steel plant in Odisha after private security guards fired at three minors Thursday, prompting ...

Related News

President lauds awareness programmes about leprosy

Awareness programmes about leprosy will help bring an attitudinal change in society towards the dise ...

How green tea rids you of oral cancer

Green tea consists of an ingredient , which may help kill oral cancer cells, without touching the healthy cells, says a ...

Online dieters who make more 'connections' lose more weight

A new study has recently revealed that people who make more connections while using an online weight ...

Post new comment

To combat spam, please enter the code in the image.

Rs. 27690 (Per 10g)

Opinion Poll
Do you think Kiran Bedi is a safe bet for BJP against a strong Kejriwal?
YesNoCan't say

Matrimony | Photos | Videos | Search | Polls | Archives | Advertise | Letters

© The Siasat Daily, 2012. All rights reserved.
Jawaharlal Nehru Road, Abids, Hyderabad - 500001, Telangana, India
Tel: +91-40-24744180, Fax: +91-40-24603188
contact@siasat.com